
insideprecisionmedicine.com
Mar 11, 2025, 09:47
Sandra McGuigan: An extraordinary 18 years of remission from neuroblastoma due to CAR-T cell therapy
Sandra McGuigan, Oncology Therapy Lead at Fortrea, shared a post on LinkedIn about a paper
“A patient has experienced an extraordinary 18 years of remission from neuroblastoma, a rare cancer of nerve cells, due to chimeric antigen receptor (CAR) T cell therapy. No further treatments were necessary!
This could potentially be the longest documented remission for a cancer patient treated with CAR-T cell therapy.”
“Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma”
Authors: Che-Hsing Li, Sandhya Sharma, Andras Heczey, Malcolm Brenner, Helen Heslop et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 11, 2025, 16:48
Mar 11, 2025, 16:33
Mar 11, 2025, 16:24
Mar 11, 2025, 15:02
Mar 11, 2025, 14:44
Mar 11, 2025, 14:12
Mar 11, 2025, 13:57